Skip to content

iRadimed IRMD International — Total Revenue

Similar metrics at other companies

Teradata logo
TDCInternational — Total Revenue
$220M+7.8%
Butterfly Network logo
BFLYInternational — Total Revenue
$5.17M+23.4%
Symbotic Inc. logo
SYMInternational — Total Revenue
$48.56M+93.1%
Veracyte logo
VCYTInternational — Total Revenue
$5.14M-7.6%
Appian Corporation logo
APPNInternational — Total Revenue
$76.04M+26.2%
Peloton Interactive, Inc. logo
PTONInternational — Total Revenue
$58.7M+12.9%

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's international — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's international — total revenue?
iRadimed (IRMD) reported international — total revenue of $3.95M in Q1 2026.
How has iRadimed's international — total revenue changed year-over-year?
iRadimed's international — total revenue increased by 11.1% year-over-year, from $3.56M to $3.95M.
What does international — total revenue mean?
This metric represents the aggregate gross income generated from all sales activities within the international geographic segment. It reflects the company's ability to capture market share and demand for its specialized medical devices outside of its primary domestic market.